Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

62 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2022.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,098,040 shares of 86,307,537 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include FMR LLC (7,228,301 shares), Casdin Capital, LLC (3,206,380 shares), BlackRock Inc. (1,409,163 shares), Avidity Partners Management LP (1,303,600 shares), FEDERATED HERMES, INC. (1,164,094 shares), VANGUARD GROUP INC (1,068,688 shares), Deep Track Capital, LP (924,641 shares), MARSHALL WACE, LLP (701,338 shares), HHLR ADVISORS, LTD. (614,095 shares), and DAFNA Capital Management LLC (475,367 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.